Sonoma Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.59 Insider Own0.39% Shs Outstand3.10M Perf Week-3.09%
Market Cap8.55M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.09M Perf Month-15.51%
Income-4.90M PEG- EPS next Q- Inst Own6.00% Short Float0.45% Perf Quarter-15.02%
Sales12.90M P/S0.66 EPS this Y17.10% Inst Trans7.73% Short Ratio0.26 Perf Half Y-0.71%
Book/sh2.57 P/B1.10 EPS next Y- ROA-25.90% Target Price- Perf Year-52.44%
Cash/sh1.85 P/C1.53 EPS next 5Y- ROE-49.60% 52W Range2.55 - 8.76 Perf YTD-37.94%
Dividend- P/FCF- EPS past 5Y36.40% ROI-50.90% 52W High-67.46% Beta0.95
Dividend %- Quick Ratio2.50 Sales past 5Y-0.30% Gross Margin32.40% 52W Low11.77% ATR0.20
Employees12 Current Ratio3.10 Sales Q/Q8.10% Oper. Margin-39.80% RSI (14)42.68 Volatility4.47% 5.35%
OptionableNo Debt/Eq0.06 EPS Q/Q45.50% Profit Margin-37.70% Rel Volume0.07 Prev Close2.83
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume52.51K Price2.85
Recom2.00 SMA20-4.90% SMA50-6.62% SMA200-19.53% Volume593 Change0.72%
Aug-11-22 04:30PM  
Aug-02-22 04:30PM  
Jul-13-22 04:45PM  
Jun-01-22 06:00AM  
May-03-22 06:00AM  
Mar-30-22 11:20AM  
Feb-11-22 04:30PM  
Jan-28-22 09:38AM  
Jan-20-22 04:40PM  
Jan-05-22 04:55PM  
Nov-15-21 08:00AM  
Nov-09-21 07:00AM  
Oct-15-21 07:44AM  
Sep-30-21 12:50PM  
Sep-29-21 03:37AM  
Sep-28-21 02:37PM  
Aug-20-21 12:19PM  
Aug-19-21 01:19PM  
Aug-16-21 04:15PM  
Jul-15-21 03:51PM  
Jul-14-21 07:56PM  
Mar-31-21 04:10PM  
Mar-11-21 09:00PM  
Mar-09-21 08:15PM  
Mar-04-21 05:03PM  
Feb-19-21 05:07PM  
Feb-16-21 05:30PM  
Feb-15-21 03:45PM  
Feb-10-21 12:50PM  
Feb-08-21 11:07AM  
Feb-02-21 08:00AM  
Feb-01-21 03:47PM  
Jan-28-21 04:30PM  
Jan-27-21 02:30PM  
Jan-18-21 06:00PM  
Jan-14-21 11:45AM  
Jan-11-21 05:30PM  
Dec-24-20 04:07PM  
Dec-23-20 12:40AM  
Dec-19-20 11:35PM  
Dec-17-20 06:17PM  
Dec-16-20 04:47PM  
Dec-12-20 08:08PM  
Dec-11-20 10:37AM  
Dec-10-20 04:10PM  
Dec-09-20 11:30PM  
Dec-08-20 03:47PM  
Dec-07-20 08:13PM  
Dec-05-20 09:20PM  
Dec-02-20 02:15PM  
Dec-01-20 01:15PM  
Nov-30-20 09:00PM  
Nov-29-20 07:45AM  
Nov-27-20 10:17AM  
Nov-26-20 01:00PM  
Nov-25-20 11:20PM  
Nov-24-20 08:47PM  
Nov-20-20 04:21PM  
Sep-18-20 07:30AM  
Sep-17-20 04:05PM  
Sep-10-20 07:20AM  
Sep-09-20 04:10PM  
Aug-14-20 04:59PM  
Jul-29-20 07:32AM  
Jul-28-20 04:05PM  
Jul-10-20 05:00PM  
May-30-20 11:59AM  
May-29-20 05:08PM  
May-28-20 04:30PM  
May-26-20 04:57PM  
Apr-28-20 09:08AM  
Feb-28-20 07:28AM  
Feb-27-20 05:00PM  
Feb-14-20 05:30PM  
Jan-29-20 11:31AM  
Jan-24-20 10:44AM  
Jan-23-20 04:43PM  
Nov-29-19 04:42PM  
Nov-26-19 10:10AM  
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.